Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Endocrine Gland Neoplasms × ganitumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma, Ewing 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Jaundice 1 Endocrine Gland Neoplasms 1

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 napabucasin 1 ganitumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01231347 2024-07-16

GAMMA

NantCell, Inc.

Phase 3 Completed

800 enrolled 11 charts

Gastrointestinal

Endocrine Gland Neoplasms, Jaundice, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡